OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
Yolanda Diz-Chaves, Zainab Mastoor, Carlos Spuch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9583-9583
Open Access | Times Cited: 37
Yolanda Diz-Chaves, Zainab Mastoor, Carlos Spuch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9583-9583
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent
Syed Faizan Mehdi, Suma Pusapati, Muhammad Saad Anwar, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 93
Syed Faizan Mehdi, Suma Pusapati, Muhammad Saad Anwar, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 93
The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets
Alhamdu Adamu, Shuo Li, Fankai Gao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 79
Alhamdu Adamu, Shuo Li, Fankai Gao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 79
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 65
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 65
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications
Saleh Hadi Alharbi
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access | Times Cited: 61
Saleh Hadi Alharbi
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access | Times Cited: 61
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Andrew McGarry, Shane Rosanbalm, Mika Leinonen, et al.
The Lancet Neurology (2023) Vol. 23, Iss. 1, pp. 37-45
Closed Access | Times Cited: 45
Andrew McGarry, Shane Rosanbalm, Mika Leinonen, et al.
The Lancet Neurology (2023) Vol. 23, Iss. 1, pp. 37-45
Closed Access | Times Cited: 45
DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease
Seong‐Jin Yu, Yun Wang, Hui Shen, et al.
GeroScience (2024) Vol. 46, Iss. 5, pp. 4349-4371
Open Access | Times Cited: 10
Seong‐Jin Yu, Yun Wang, Hui Shen, et al.
GeroScience (2024) Vol. 46, Iss. 5, pp. 4349-4371
Open Access | Times Cited: 10
Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer’s disease models: a systematic review and meta-analysis of preclinical studies
Fanjing Kong, Tianyu Wu, Jiyan Dai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Fanjing Kong, Tianyu Wu, Jiyan Dai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Cerebral glucagon‐like peptide‐1 receptor activation alleviates traumatic brain injury by glymphatic system regulation in mice
Chuanxiang Lv, Shuai Han, Zhuang Sha, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 12, pp. 3876-3888
Open Access | Times Cited: 15
Chuanxiang Lv, Shuai Han, Zhuang Sha, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 12, pp. 3876-3888
Open Access | Times Cited: 15
The GLP-1 receptor agonist exenatide improves recovery from spinal cord injury by inducing macrophage polarization toward the M2 phenotype
Toshihiro Noguchi, Hiroyuki Katoh, Satoshi Nomura, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
Toshihiro Noguchi, Hiroyuki Katoh, Satoshi Nomura, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
Association Between Glucagon-Like Peptide-1 Receptor Agonists Exposure and Intraocular Pressure Change
Shahin Hallaj, William Halfpenny, Benton Chuter, et al.
American Journal of Ophthalmology (2024) Vol. 269, pp. 255-265
Open Access | Times Cited: 4
Shahin Hallaj, William Halfpenny, Benton Chuter, et al.
American Journal of Ophthalmology (2024) Vol. 269, pp. 255-265
Open Access | Times Cited: 4
Dysregulation of Metabolic Peptides in the Gut–Brain Axis Promotes Hyperinsulinemia, Obesity, and Neurodegeneration
Camille Green, Vandana Zaman, Kayce Blumenstock, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 132-132
Open Access
Camille Green, Vandana Zaman, Kayce Blumenstock, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 132-132
Open Access
Emerging insights into the impact of systemic metabolic changes on tumor-immune interactions
Andrea L Cote, Chad J. Munger, Alison E. Ringel
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115234-115234
Closed Access
Andrea L Cote, Chad J. Munger, Alison E. Ringel
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115234-115234
Closed Access
Glucagon-like peptide-1 receptor agonism and end-organ protection
Samuel J. Daniels, Cecilia Karlsson, Patrick Schrauwen, et al.
Trends in Endocrinology and Metabolism (2025)
Open Access
Samuel J. Daniels, Cecilia Karlsson, Patrick Schrauwen, et al.
Trends in Endocrinology and Metabolism (2025)
Open Access
From Gut to Brain: The Role of Gut Dysbiosis, Bacterial Amyloids, and Metabolic Disease in Alzheimer’s Disease
Saadet Inan, R. Paul Wilson, Çağla Tükel
Pharmacological Research (2025), pp. 107693-107693
Open Access
Saadet Inan, R. Paul Wilson, Çağla Tükel
Pharmacological Research (2025), pp. 107693-107693
Open Access
1,25‐D3 Protects Diabetic Brain Injury Through GLP‐1R/PI3K/Akt Pathway by Experimental and Molecular Docking Studies
Ting Song, Bin Wang, Yutian Li, et al.
Mediators of Inflammation (2025) Vol. 2025, Iss. 1
Open Access
Ting Song, Bin Wang, Yutian Li, et al.
Mediators of Inflammation (2025) Vol. 2025, Iss. 1
Open Access
The effect of GLP-1RAs on mental health and psychotropics-induced metabolic disorders: A systematic review
Sigrid Breit, Daniela Hubl
Psychoneuroendocrinology (2025), pp. 107415-107415
Closed Access
Sigrid Breit, Daniela Hubl
Psychoneuroendocrinology (2025), pp. 107415-107415
Closed Access
Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agents in autoimmune diseases
Yuanyuan Yang, Wencong Liu, Zechang Zhang, et al.
Journal of Autoimmunity (2025) Vol. 153, pp. 103414-103414
Closed Access
Yuanyuan Yang, Wencong Liu, Zechang Zhang, et al.
Journal of Autoimmunity (2025) Vol. 153, pp. 103414-103414
Closed Access
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias
Huilin Tang, William T. Donahoo, Steven T. DeKosky, et al.
JAMA Neurology (2025)
Closed Access
Huilin Tang, William T. Donahoo, Steven T. DeKosky, et al.
JAMA Neurology (2025)
Closed Access
Glycated hemoglobin and body mass index as mediators of GLP‐1RAs and Alzheimer's disease and related dementias in patients with type 2 diabetes
Huilin Tang, William T. Donahoo, Steven T. DeKosky, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access
Huilin Tang, William T. Donahoo, Steven T. DeKosky, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access
Neuroprotective effects of Saxagliptin in traumatic brain injury: ameliorating oxidative stress, neuroinflammation, and apoptosis
Bhagyashree Baral, Chandan Chauhan, Tushar Mishra, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 4
Closed Access
Bhagyashree Baral, Chandan Chauhan, Tushar Mishra, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 4
Closed Access
GLP-1 analogue liraglutide attenuates CIH-induced cognitive deficits by inhibiting oxidative stress, neuroinflammation, and apoptosis via the Nrf2/HO-1 and MAPK/NF-κB signaling pathways
Renjun Lv, Yan Zhao, Xiao Wang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113222-113222
Closed Access | Times Cited: 4
Renjun Lv, Yan Zhao, Xiao Wang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113222-113222
Closed Access | Times Cited: 4
Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative Disorders: A Large-Scale Propensity-Matched cohort study
Nabeela Siddeeque, Mohammad H. Hussein, Ahmed Abd‐Elmaksoud, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113537-113537
Open Access | Times Cited: 4
Nabeela Siddeeque, Mohammad H. Hussein, Ahmed Abd‐Elmaksoud, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113537-113537
Open Access | Times Cited: 4
Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain
Yolanda Diz-Chaves, Zainab Maastor, Carlos Spuch, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 8, pp. 1671-1677
Open Access | Times Cited: 10
Yolanda Diz-Chaves, Zainab Maastor, Carlos Spuch, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 8, pp. 1671-1677
Open Access | Times Cited: 10
GLP-1/Sigma/RAGE receptors: An evolving picture of Alzheimer's disease pathology and treatment
Neha Neha, Zitin Wali, Pinky Pinky, et al.
Ageing Research Reviews (2023) Vol. 93, pp. 102134-102134
Closed Access | Times Cited: 7
Neha Neha, Zitin Wali, Pinky Pinky, et al.
Ageing Research Reviews (2023) Vol. 93, pp. 102134-102134
Closed Access | Times Cited: 7
Cyclic Adenosine Monophosphate in Cardiac and Sympathoadrenal GLP-1 Receptor Signaling: Focus on Anti-Inflammatory Effects
Anastasios Lymperopoulos, Jordana I. Borges, Renee A. Stoicovy
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 693-693
Open Access | Times Cited: 2
Anastasios Lymperopoulos, Jordana I. Borges, Renee A. Stoicovy
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 693-693
Open Access | Times Cited: 2
